National Resilience Restructures Manufacturing Footprint, Closes 6 of 10 Plants
National Resilience will close six of its ten manufacturing sites in the US.
The closures affect facilities in Massachusetts (3), California (2), and one additional location.
The company aims to streamline operations and focus on high-growth segments such as cell-based therapies.
Resilience’s Cincinnati facility and ongoing operations remain fully operational and unaffected by the closures.
The move addresses overcapacity issues following a biotech downturn and expansion outpacing demand.